$DXCM DEXCOM INC Insider Trading Week 11/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DEXCOM INC in week 11/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2017 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 77.36 | 3,000 | 232,080 | 21,304 | 24.3 K to 21.3 K (-12.34 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Option Exercise | M | 7.63 | 7,500 | 57,225 | 0 | |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | S | 77.32 | 3,050 | 235,824 | 82,155 | 85.2 K to 82.2 K (-3.58 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | S | 77.78 | 2,732 | 212,485 | 85,205 | 87.9 K to 85.2 K (-3.11 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | S | 78.07 | 5,194 | 405,506 | 87,937 | 93.1 K to 87.9 K (-5.58 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Buy | M | 7.63 | 7,500 | 57,225 | 93,131 | 85.6 K to 93.1 K (+8.76 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | D | 77.55 | 2,538 | 196,823 | 85,631 | 88.2 K to 85.6 K (-2.88 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | D | 77.55 | 5,473 | 424,434 | 88,169 | 93.6 K to 88.2 K (-5.84 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | D | 77.55 | 1,950 | 151,224 | 93,642 | 95.6 K to 93.6 K (-2.04 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | S | 77.24 | 3,012 | 232,650 | 95,592 | 98.6 K to 95.6 K (-3.05 %) |
Mar 15 2017 | DXCM | DEXCOM INC | Leach Jacob Steven | SVP, Research & Dev ... | Sell | S | 77.56 | 7,329 | 568,423 | 98,604 | 105.9 K to 98.6 K (-6.92 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 77.74 | 14,400 | 1,119,514 | 10,442 | 24.8 K to 10.4 K (-57.97 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 77.55 | 3,964 | 307,411 | 24,842 | 28.8 K to 24.8 K (-13.76 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 77.55 | 6,694 | 519,124 | 28,806 | 35.5 K to 28.8 K (-18.86 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 78.24 | 12,667 | 991,066 | 35,500 | 22.8 K to 35.5 K (+55.48 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 78.24 | 7,500 | 586,800 | 22,833 | 15.3 K to 22.8 K (+48.91 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 78.24 | 11,834 | 925,892 | 15,333 | 3.5 K to 15.3 K (+338.21 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 77.55 | 6,254 | 485,001 | 34,079 | 40.3 K to 34.1 K (-15.51 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 78.24 | 12,667 | 991,066 | 40,333 | 53 K to 40.3 K (-23.90 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 78.24 | 7,500 | 586,800 | 53,000 | 60.5 K to 53 K (-12.40 %) |
Mar 14 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 78.24 | 11,834 | 925,892 | 60,500 | 72.3 K to 60.5 K (-16.36 %) |
Mar 14 2017 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 77.55 | 5,120 | 397,059 | 46,497 | 51.6 K to 46.5 K (-9.92 %) |
Mar 14 2017 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 77.55 | 1,948 | 151,069 | 51,617 | 53.6 K to 51.6 K (-3.64 %) |
Mar 14 2017 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 77.55 | 2,538 | 196,823 | 53,565 | 56.1 K to 53.6 K (-4.52 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 77.55 | 5,813 | 450,802 | 64,664 | 70.5 K to 64.7 K (-8.25 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 77.55 | 2,867 | 222,338 | 70,477 | 73.3 K to 70.5 K (-3.91 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 77.55 | 3,213 | 249,170 | 73,344 | 76.6 K to 73.3 K (-4.20 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 78.24 | 11,000 | 860,640 | 76,557 | 65.6 K to 76.6 K (+16.78 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 78.24 | 6,667 | 521,626 | 65,557 | 58.9 K to 65.6 K (+11.32 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 78.24 | 8,334 | 652,052 | 58,890 | 50.6 K to 58.9 K (+16.48 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 78.24 | 11,000 | 860,640 | 57,486 | 68.5 K to 57.5 K (-16.06 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 78.24 | 6,667 | 521,626 | 68,486 | 75.2 K to 68.5 K (-8.87 %) |
Mar 14 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 78.24 | 8,334 | 652,052 | 75,153 | 83.5 K to 75.2 K (-9.98 %) |
Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 77.55 | 3,208 | 248,782 | 116,033 | 119.2 K to 116 K (-2.69 %) |
Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 77.55 | 6,694 | 519,124 | 119,241 | 125.9 K to 119.2 K (-5.32 %) |
Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 77.55 | 3,528 | 273,599 | 125,935 | 129.5 K to 125.9 K (-2.73 %) |
Mar 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 77.71 | 3,200 | 248,672 | 129,463 | 132.7 K to 129.5 K (-2.41 %) |